Impact of treatment with agalsidasebeta on health-related quality of life in patients with Fabry disease - Badia, X.; Perez, P.; Layola, M.; Checa, D.; Tutor, A.; Álvarez, A.; Torra, R.; Torras, J.; de Arriba, G.; García-Moncó, C.; Puig, J.M.; Torregrosa, V. (Clinical Therapeutics, 2007)